Life Sciences Funding in Europe (2007)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Life Sciences Funding in Europe (2007) analyses the public, private and charity funding scenario in European Countries. Analysis of the Framework Programme 7 and other funding organisations in Europe has been provided. The countries included in the analysis are the United Kingdom, Germany, France, Italy and Spain. Challenges faced by the European R&D funding system and the efforts taken by the countries to tackle these problems have been analysed.

Table of Contents

Life Sciences Funding in Europe (2007), Executive SummaryOverview of the Life Sciences Funding in EuropeExecutive Summary of the Life Sciences Funding in EuropeLife Sciences Funding in Europe (2007), GlossaryGlossary of TermsTerminologiesKey AcronymsAcronymsLife Sciences Funding in Europe (2007), Assumptions and MethodologyResearch Scope and MethodologyResearch Scope and SegmentationLife Sciences Funding in Europe (2007), Funding in EuropeFunding LandscapeFunding ScenarioEuropean Funding OverviewEuropean Funding ChallengesMarket Engineering MeasurementsFunding AnalysisLife Sciences Funding in Europe (2007), Funding in the United KingdomFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2007), Funding in GermanyFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2007), Funding in FranceFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2007), Funding in ItalyFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2007), Funding in SpainFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2007), Decision Support DatabaseDatabase TablesBiotech CompaniesBiotech Private InvestmentPer cent of Government Investment in BiotechnologyGovernment Biotech R&D InvestmentEnrollment of Students




Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.